20 LATEST RESOURCES (175 INDEXED)
Predicting Amyloid PET Positivity Using Plasma P-tau181 and Other Blood-Based Biomarkers · November 2023
Articles
Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring
FDG-PET-Based Neural Correlates of Addenbrooke’s Cognitive Examination III Scores in Alzheimer’s Disease and Frontotemporal Degeneration · November 2023
Articles
Frontiers in Psychology
Agreement of Cerebrospinal Fluid Biomarkers and Amyloid-PET in a Multicenter Study · October 2023
Articles
European Archives of Psychiatry and Clinical Neuroscience
Neurological and Psychiatric Manifestations of Long COVID-19 and Their [18F]FDG PET Findings: A Review · July 2023
Articles
Diagnostics
Advances in Diagnosing Mild Cognitive Impairment and Alzheimer’s Disease Using 11C-PIB- PET/CT and Common Neuropsychological Tests · July 2023
Articles
Frontiers in Neuroscience
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook · May 2023
Articles
Diagnostics
Tau-PET Imaging in Parkinson’s Disease: A Systematic Review and Meta-Analysis · April 2023
Articles
Frontiers in Neurology
Antiviral Treatment in Schizophrenia: A Randomized Pilot PET Study on the Effects of Valaciclovir on Neuroinflammation · April 2023
Articles
Psychological Medicine
Analysis of Positron Emission Tomography Hypometabolic Patterns and Neuropsychiatric Symptoms in Patients with Dementia Syndromes · March 2023
Articles
CNS Neuroscience and Therapeutics
Utility of Amyloid Positron Emission Tomography Imaging in Older Adults with Epilepsy and Cognitive Decline · March 2023
Articles
American Journal of Alzheimer’s Disease and Other Dementias
Amyloid-B PET in Alzheimer’s Disease: A Systematic Review and Bayesian Meta-Analysis · December 2022
Articles
Brain and Behavior
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials · December 2022
Articles
Journal of Alzheimer’s Disease
Involvement of Inflammation in the Medial Temporal Region in the Development of Agitation in Alzheimer’s Disease: An In Vivo Positron Emission Tomography Study · November 2022
Articles
Psychogeriatrics
Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases · October 2022
Articles
NCBI>Neurology
Monitoring Alzheimer’s Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods · October 2022
Articles
Journal of Alzheimer’s Disease
Atypical Alzheimer’s Disease Phenotypes with Normal or Borderline PET Biomarker Profiles · August 2022
Articles (Manuscripts-Versions)
PubMed Central>Journal of Neurology
Effect of Cognitive Reserve on Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease Defined by Fluorodeoxyglucose-Positron Emission Tomography · August 2022
Articles
Frontiers in Aging Neuroscience
Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment · June 2022
Articles
Journal of Clinical Medicine
Application of Positron Emission Tomography in Psychiatry-Methodological Developments and Future Directions · June 2022
Articles
Translational Psychiatry